Clinical Trials Browser

OTHER × Triple Negative Breast Neoplasms × Immunohistochemistry × Clear all

NCT00918892 2022-08-01

Assessment of Candidate Protein Expression in Breast Cancer Specimens

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01009983 2018-07-06

Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast Cancer

Phase 2 Terminated

14 enrolled 11 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01105312 2017-06-27

Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer

Phase 1/2 Completed

28 enrolled 13 charts

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT01292083 2014-02-06

Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By Surgery

Phase NA Withdrawn

Breast Neoplasms, Triple Negative Breast Neoplasms